In silico repositioning of approved drugs for rare and neglected diseases.

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

• Drug repositioning for personalized medicine.

  Authors: Yvonne Y Li, Steven Jm Jones

  Genome medicine. 4(3):27.

• Reverse pharmacognosy: another way to harness the generosity of nature.

  Authors: S Blondeau, Q T Do, T Scior, P Bernard, L Morin-Allory

  Current pharmaceutical design. 16(15):1682-96.

• Drug repositioning for orphan diseases.

  Authors: Divya Sardana, Cheng Zhu, Minlu Zhang, Ranga C Gudivada, Lun Yang, Anil G Jegga

  Briefings in bioinformatics. 12(4):346-56.

• Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs.

  Authors: W H Bisson, A V Cheltsov, N Bruey-Sedano, B Lin, J Chen, N Goldberger, L T May, A Christopoulos, J T Dalton, P M Sexton, X K Zhang, R Abagyan

  Proceedings of the National Academy of Sciences of the United States of America. 104(29):11927-32.

• Medicinal plants from Peru: a review of plants as potential agents against cancer.

  Authors: Gustavo F Gonzales, Luis G Valerio

  Anti-cancer agents in medicinal chemistry. 6(5):429-44.

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.